Median rhomboid glossitis
ICD-10 K14.2 is a billable code used to indicate a diagnosis of median rhomboid glossitis.
Median rhomboid glossitis is a condition characterized by a smooth, red, and often painful area located in the midline of the dorsal surface of the tongue. This condition is thought to be associated with a chronic fungal infection, particularly Candida albicans, and may also be linked to other factors such as vitamin deficiencies, particularly B vitamins, or autoimmune conditions. The clinical presentation typically includes a loss of papillae in the affected area, resulting in a shiny appearance. Patients may experience discomfort, burning sensations, or changes in taste. The anatomy involved primarily includes the tongue's mucosal surface, where inflammation can lead to the characteristic glossitis. Disease progression can vary; while some patients may experience spontaneous resolution, others may have persistent symptoms requiring treatment. Diagnostic considerations include a thorough clinical examination, patient history, and, if necessary, laboratory tests to rule out underlying causes such as nutritional deficiencies or systemic diseases. A biopsy is rarely needed but may be considered in atypical cases.
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
Standard ICD-10-CM documentation requirements apply
Various clinical presentations within this specialty area
Follow specialty-specific billing guidelines
K14.2 specifically covers median rhomboid glossitis, which may be associated with candidiasis, nutritional deficiencies, or autoimmune disorders. It is important to differentiate this condition from other types of glossitis and oral lesions.
K14.2 should be used when the clinical presentation specifically matches median rhomboid glossitis, characterized by a smooth, red area on the tongue's midline. If the presentation is more generalized or lacks the characteristic features, other codes such as K14.0 or K14.1 may be more appropriate.
Documentation for K14.2 should include a detailed clinical examination, patient history focusing on symptoms, potential risk factors, and any relevant laboratory findings. Evidence of treatment response or persistence of symptoms may also be necessary.
